Novartis clinical updates pause trials after patient deaths
Novartis said it halted trials for one experimental drug following a spate of patient deaths, while also disclosing positive data for a pill analysts view as a potential blockbuster.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.